Calcimedica to participate in the piper sandler 36th annual healthcare conference

La jolla, calif. , nov. 21, 2024 /prnewswire/ -- calcimedica inc. ("calcimedica" or the "company") (nasdaq: calc), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (crac) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that rachel leheny, ph.d.

CALC Ratings Summary

CALC Quant Ranking